A guide to potential immunotoxic effects that might be
associated with medical device materials.
Ref: http://www.fda.gov/cdrh/ost/ostggp/immunotox.html#T1
BODY CONTACT |
CONTACT DURATION |
IMMUNOTOXIC EFFECTS |
|||||
1 |
2 |
3 |
4 |
5 |
|||
Surface Devices - |
Skin |
A |
pmbx |
|
x |
|
|
B |
pmbx |
x |
x |
x |
x |
||
C |
pmbx |
x |
x |
x |
x |
||
Mucosal Membranes |
A |
pmbx |
|
x |
|
|
|
B |
pmbx |
pmbx |
mbx |
x |
x |
||
C |
pmbx |
pmbx |
mbx |
mbx |
mbx |
||
Breached or Compromised Surface |
A |
pmbx |
|
x |
|
|
|
B |
pmbx |
pmbx |
mbx |
mbx |
mbx |
||
C |
pmbx |
pmbx |
mbx |
mbx |
mbx |
||
External Communicating Devices - External devices that contact the circulating blood (e.g. dialyzers and immunoadsorbents); or the blood path indirectly at one point and serve as a conduit for entry into the vascular system (e.g. solution and blood administration sets); or tissue/bone/dentin (e.g. skin staples, laparoscopes, dental filling materials) |
Blood Path, |
A |
pmbx |
|
x |
|
|
B |
pmbx |
pmbx |
mbx |
pmbx |
mbx |
||
C |
pmbx |
pmbx |
mbx |
pmbx |
mbx |
||
Tissue/Bone/Dentin Communicating |
A |
pmbx |
|
x |
|
|
|
B |
pmbx |
cpmbx |
mbx |
pmbx |
mbx |
||
C |
pmbx |
cpmbx |
mbx |
pmbx |
mbx |
||
Implant Devices - |
Tissue/Bone, Blood, and other Body Fluids |
A |
pmbx |
|
x |
|
|
B |
pmbx |
cpmbx |
mbx |
pmbx |
mbx |
||
C |
pmbx |
cpmbx |
mbx |
pmbx |
mbx |
A = Limited ( </= 24 hrs) |
Effects Expected for Various
Materials: |